3 Big Pharmas That Could be Winners for Investors in the Long Run Post author:Sam Post published:November 29, 2017 Post category:BioPharma Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace You Might Also Like Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017 Bioanalytical Systems, Inc. To Release First Quarter Fiscal 2017 Results On Tuesday, February 14, 2017 February 12, 2017 BOC Sciences's New Services-Antibody Drug Conjugates Service March 9, 2017
Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017
Bioanalytical Systems, Inc. To Release First Quarter Fiscal 2017 Results On Tuesday, February 14, 2017 February 12, 2017
